PFBT
JAZZ icon

Parkside Financial Bank & Trust’s Jazz Pharmaceuticals JAZZ Stock Holding History

Parkside Financial Bank & Trust’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.4K Buy
238
+1
+0.4% +$219 ﹤0.01% 993
2026
Q1 		$44.8K Hold
237
– – ﹤0.01% 1000
2025
Q4 		$40.3K Buy
237
+40
+20% +$6.13K ﹤0.01% 1045
2025
Q3 		$26K Sell
197
-81
-29% -$9.71K ﹤0.01% 1154
2025
Q2 		$29.5K Buy
278
+50
+22% +$5.43K ﹤0.01% 1088
2025
Q1 		$28.3K Buy
228
+111
+95% +$14.5K ﹤0.01% 1021
2024
Q4 		$14.4K Buy
117
+42
+56% +$4.95K ﹤0.01% 1184
2024
Q3 		$8.36K Buy
75
+8
+12% +$877 ﹤0.01% 1305
2024
Q2 		$7.15K Sell
67
-62
-48% -$6.82K ﹤0.01% 1275
2024
Q1 		$15.5K Buy
129
+88
+215% +$10.8K ﹤0.01% 1071
2023
Q4 		$5.04K Sell
41
-147
-78% -$18.3K ﹤0.01% 1306
2023
Q3 		$24.3K Buy
188
+17
+10% +$2.27K 0.01% 841
2023
Q2 		$21.2K Buy
171
+144
+533% +$19.4K 0.01% 872
2023
Q1 		$3.95K Sell
27
-2
-7% -$296 ﹤0.01% 1457
2022
Q4 		$4.62K Buy
29
+2
+7% +$293 ﹤0.01% 1351
2022
Q3 		$4K Hold
27
– – ﹤0.01% 1309
2022
Q2 		$4K Hold
27
– – ﹤0.01% 1338
2022
Q1 		$4K Hold
27
– – ﹤0.01% 1385
2021
Q4 		$3K Sell
27
-14
-34% -$1.84K ﹤0.01% 1500
2021
Q3 		$5K Buy
41
+14
+52% +$2.12K ﹤0.01% 1241
2021
Q2 		$5K Hold
27
– – ﹤0.01% 1233
2021
Q1 		$4K Hold
27
– – ﹤0.01% 1279
2020
Q4 		$4K Buy
27
+3
+13% +$447 ﹤0.01% 1196
2020
Q3 		$3K Sell
24
-12
-33% -$1.49K ﹤0.01% 1057
2020
Q2 		$4K Hold
36
– – ﹤0.01% 985
2020
Q1 		$4K Buy
36
+10
+38% +$1.29K ﹤0.01% 926
2019
Q4 		$4K Sell
26
-15
-37% -$2.04K ﹤0.01% 996
2019
Q3 		$5K Hold
41
– – ﹤0.01% 935
2019
Q2 		$6K Buy
41
+26
+173% +$3.49K ﹤0.01% 910
2019
Q1 		$2K Buy
+15
New +$1.96K ﹤0.01% 1168

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Parkside Financial Bank & Trust's JAZZ Position: Q2 2026 in Review

Parkside Financial Bank & Trust increased its Jazz Pharmaceuticals (JAZZ) stake by 0.42% in Q2 2026, buying an estimated $219 and bringing the position to 238 shares worth $57.4K. The position accounts for ﹤0.01% of the portfolio, ranked #993.

Parkside Financial Bank & Trust first reported a position in JAZZ in Q1 2019 and has held it in 30 quarters since. 647 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Parkside Financial Bank & Trust held 238 shares of Jazz Pharmaceuticals worth $57.4K as of Q2 2026.
  • Parkside Financial Bank & Trust bought 1 Jazz Pharmaceuticals share in Q2 2026, an estimated $219.
  • Jazz Pharmaceuticals made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q2 2026, its #993 holding.
  • Parkside Financial Bank & Trust first reported a position in Jazz Pharmaceuticals in Q1 2019 and has held it in 30 quarters since.
  • 647 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q2 2026, filed 4 Sep 2026.